Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase III, Randomized, Open Label Study Evaluating the Safety of Apixaban in Subjects With Cancer Related Venous Thromboembolism

NCT02585713 is registered in ClinicalTrials.gov with Academic and Community Cancer Research United as lead sponsor.

NCT NCT02585713
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02585713 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase III, Randomized, Open Label Study Evaluating the Safety of Apixaban in Subjects With Cancer Related Venous Thromboembolism
Lead sponsor
Academic and Community Cancer Research United
Phase
Phase 3
Overall status
Completed
Start date
November 20, 2015
Completion date
December 24, 2019
Enrollment
300 (actual)
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

cerebral vein thrombosis, deep vein thrombosis, gonadal thrombosis, hepatic thrombosis, malignant neoplasm, mesenteric thrombosis, metastatic malignant neoplasm, portal vein thrombosis, pulmonary embolism, renal vein thrombosis, splenic thrombosis, venous thromboembolism